Murici para Inflamación sistémica
Byrsonima verbascifolia — 15 estudios científicos revisados
Preliminary¿Sirve Murici para inflamación sistémica?
La presencia de compuestos bioactivos como flavonoides y terpenos sugiere un potencial antiinflamatorio que ayuda a reducir la respuesta inmunitaria excesiva [PMID 29389624].
Compuestos activos involucrados: Alcaloides, Flavonoides, Saponina, Saponinas, Taninos, Terpenos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Murici y inflamación sistémica:
Anti-inflammatory effects of the butanolic fraction of Byrsonima verbascifolia leaves: Mechanisms involving inhibition of tumor necrosis factor alpha, prostaglandin E(2) production and migration of polymorphonuclear leucocyte in vivo experimentation.
The leaves of Byrsonima verbascifolia (Malpighiaceae) are traditionally used to treat various diseases including inflammatory conditions. The main goal of this study was to evaluate the in vivo anti-inflammatory activity of the polar constituents from the butanolic fraction of B. verbascifolia leaves (BvBF), as well as to investigate the mechanisms involved in the anti-inflammatory activity. The polar constituents were identified by liquid chromatography coupled to diode array detector and mass spectrometry (LC-DAD–MS) and matrix-assisted laser desorption/ionization – time-of-flight mass spect
PubMed: 26724477Small Brazilian wild fruits: Nutrients, bioactive compounds, health-promotion properties and commercial interest.
Brazilian berries present great nutritional, functional and economic characteristics comparable to temperate berries. They constitute an important innovation domain for the food, pharmaceutical and cosmetic industries, due to their positive health effects and market potential. The main objective of this review was to describe the physicochemical, nutritional and biological aspects of six Brazilian small native wild fruits from the Arecaceae (açaí, buriti and pupunha), Mirtaceae (camu-camu and jaboticaba) and Malpighiaceae (murici) families, highlighting their antioxidant, anti-lipidaemic, anti
PubMed: 29389624Screening of Brazilian medicinal plants for antiviral activity against rotavirus.
ETHNOPHARMACOLOGICAL RELEVANCE: Brazilian medicinal plants traditionally used for the treatment of diarrhoea were investigated for their in vitro antiviral activity against the simian rotavirus SA11. MATERIALS AND METHODS: The ethanolic crude extracts of plants collected in the cerrado of Minas Gerais, Brazil were submitted to phytochemical screening. The cytotoxicity of the extracts was inferred by cellular morphologic alterations. Antiviral activity was assessed by the ability of the extracts to inhibit the cytopathic effect (CPE) of rotavirus on the treated cells. RT-PCR was performed to co
PubMed: 22469769Chemical composition and anti-inflammatory activity of the leaves of Byrsonima verbascifolia.
An ethnopharmacological survey indicates that the genus Byrsonima has some medicinal species that are commonly found in the Brazilian Cerrado and has been used as an anti-inflammatory and for gastroduodenal disorders. The aim of this study was to evaluate the anti-inflammatory and antioxidant activity along with qualitative chemical characterization of the methanolic extract of the leaves of Byrsonima verbascifolia (BvME) obtained by exhaustive percolation. The data from the chemical analyses by liquid chromatography-mass spectrometry led to tentative identification of 42 compounds belonging t
PubMed: 27278224Phytochemical screening, total phenolic content and antioxidant activity of Byrsonima species.
The species of the Byrsonima genus (Malpighiaceae) have been used in folk medicine to treat gastrointestinal disorders, asthma and skin infections. In this study, the total phenolic content, antioxidant activity and phytochemical screening were carried out in polar extracts of Byrsonima coccolobifolia, Byrsonima verbascifolia and Byrsonima intermedia. The presence of tannins and flavonoids in the samples and high phenols content was observed. B. coccolobifolia and B.
PubMed: 25604883Seguridad y Precauciones
La seguridad en el uso de Byrsonima verbascifolia (Murici) debe abordarse con extrema cautela debido a la escasez de ensayos clínicos controlados en humanos, lo que limita nuestra capacidad de establecer protocolos de dosificación seguros. En relación con el embarazo y la lactancia, no existe evidencia científica suficiente que garantice la ausencia de efectos teratogénicos (anomalías en el desarrollo fetal) o alteraciones en la composición de la leche materna. Dado que la planta contiene metabolitos secundarios como saponinas y taninos, que pueden cruzar la barrera placentaria o excretarse en la leche, se recomienda evitar su consumo terapéutico en estas etapas para prevenir riesgos potenciales no cuantificados. Para la población pediátrica, específicamente niños menores de 12 años, el uso debe ser evitado; sus sistemas metabólicos, especialmente el hígado y los riñones, están en desarrollo y la toxicidad de los alcaloides y terpenos presentes en la planta podría comprometer la función enzimática inmadura. En cuanto a las interacciones farmacológicas, se debe prestar especial atención a los pacientes que consumen warfarina (anticoagulantes), ya que los compuestos fenólicos y flavonoides presentes en el fruto pueden alterar la agregación plaquetaria o el metabolismo hepático, intensificando el riesgo de hemorragias. Asimismo, existe un riesgo potencial de interacción con la metformina debido a la presencia de compuestos que podrían alterar la absorción intestinal o la respuesta glucémica, y con fármacos antihipertensivos, dado que los efectos antioxidantes y astringentes podrían potenciar o interferir con la regulación de la presión arterial.
Otras plantas estudiadas para Inflamación sistémica
Perfil completo: Ver todos los usos y evidencia de Murici →